| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
BTBD3 Blocking Peptide for STJ500298 is synthetically produced from the 410-460 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
BTBD3 |
| Gene ID: |
22903 |
| Uniprot ID: |
BTBD3_HUMAN |
| Immunogen Region: |
410-460 |
| Specificity: |
This blocking peptide is recommended for use in combination with BTBD3 antibody, STJ500298 |
| Immunogen: |
Synthetic peptide taken within amino acid region 410-460 on human BTBD3 protein. |
| Function | Acts as a key regulator of dendritic field orientation during development of sensory cortex. Also directs dendrites toward active axon terminals when ectopically expressed. |
| Peptide Name | Btb/Poz Domain-Containing Protein 3 |
| Cellular Localisation | CytoplasmCytosolNucleusTranslocates From The Cytosol To The Nucleus In Response To Neuronal Activity |
| Alternative Peptide Names | Btb/Poz Domain-Containing Protein 3 proteinBTBD3 proteinKIAA0952 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
